Exelixis Inc Revenue per Employee (EXEL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Exelixis Inc   (NASDAQ: EXEL)
 

Exelixis Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 10.19% in the third quarter 2026, year on year to cumulative value of $2,497 million, Exelixis Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,176,862, this is below the company average.
Within the Healthcare sector Employees of 28 other companies have achieved higher revenue per employee. While Exelixis Inc 's total ranking has deteriorated compared to the previous quarter from 282 to 414. Exelixis Inc has 1,147 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EXEL Revenue per Employee (Oct 02 2026)
III. Quarter		 (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Jan 02 2026)
IV. Quarter		 (Oct 03 2025)
III. Quarter
Y / Y Revenue Change 10.19 % 10.63 % 9.97 % 5.63 % 10.79 %
Sales per Employee (TTM) $ 2,176,862 2,123,731 2,071,047 2,022,778 1,994,959
EXEL's Total Ranking # 414 # 282 # 111 # 203 #
Seq. Revenue Change 4.77 % 2.93 % 2.03 % 0.15 % 5.19 %

EXEL Company Profile >> Back to EXEL Efficiency Comparisons >> Compare EXEL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 29
Overall Market # 414

Revenue per Employee Statistics
High Average Low
$ 2,123,731 $ 797,227 $ 18,553
(Jul 03 2026)   (Jun 30 2014)



Financial Statements
Exelixis Inc 's Revenue MRQ $ 659 Millions Visit EXEL's Income Statement
Exelixis Inc 's Revenues TTM $ 2,497 Millions Visit EXEL's aggregate revenue growth
What are EXEL's Sales? Visit EXEL's Sales by Segment




Other Ratios
Exelixis Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
EXEL's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for EXEL's Competitors
Revenue per Employee for EXEL's Suppliers
Revenue per Employee for EXEL's Customers

You may also want to know
EXEL's Sales Growth Rates EXEL's Pe Price to earnings ratio EXEL's Receivables Turnover Ratio EXEL's Stock Quote
EXEL's Net Income Growth Rates EXEL's Ps Price to Sales ratio EXEL's Sales per Employee EXEL's Asset Turnover Ratio
EXEL's Net Margin EXEL's Pb Price to Book ratio EXEL's Financial Strength Ratios EXEL's Dividend Payout Ratio
Date modified: 2026-10-30T16:59:37+00:00




Companies with similar Revenue per Employee for 12 months ending Oct 02 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Oct 02 2026Number of Employees Oct 02 2026
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Amgen Inc   2,992,538.46 $ 38,903.000  Million 13,000 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.